Glad to share this CRISPR study in @hxu1101 lab, working together with @Leon9168 and @Rongj_Fu, we performed high-throughput viability screens and off-target screens using two Cas9 variants: HiFi and LZ3 and revealed guide-specific loss of efficiency and off-target reduction.
Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. https://t.co/bSer4maIjF @Ludwig_Cancer
Itโs a pleasure to share our recent study about CRISPR off-targeting and allele-specific editing, which is now published on @NatureComms. Iโm glad to work together with @Rongj_Fu to finish this project under the guidance of @hxu1101.
https://t.co/b2qXqhMiis